Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 38 results
Filters: Author is Eron, Joseph J  [Clear All Filters]
Found 38 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

E

Kitahata MM, Gange SJ, Abraham AG, et al. "Effect of early versus deferred antiretroviral therapy for HIV on survival." N. Engl. J. Med.. 2009;360(18):1815-26.
Bakshi RP, Hamzeh F, Frank I, et al. "Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients." AIDS Res. Hum. Retroviruses. 2007;23(11):1360-5.
Eron JJ, Bosch RJ, Bettendorf D, Petch L, Fiscus S, Frank I. "The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine." J. Acquir. Immune Defic. Syndr.. 2007;45(2):249-51.
Gandhi RT, Zheng L, Bosch RJ, et al. "The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial." PLoS Med.. 2010;7(8).
Taiwo B, Zheng L, Gallien S, et al. "Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)." AIDS. 2011;25(17):2113-22.
Li L, Eron JJ, Ribaudo H, Gulick RM, Johnson BA. "Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095." J Am Stat Assoc. 2012;107(498):542-554.
Jacobson JM, R Bucy P, Spritzler J, et al. "Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068." J. Infect. Dis.. 2006;194(5):623-32.

Pages